The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19711 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Morten Orebo Holmström und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, National Center for Cancer Immune Therapy, Herlev University Hospital, Herlev, Denmark. Hauptthemen laut MEDLINE: Calreticulin, Janus Kinase 2, Lymphocytes, Membrane Proteins. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Raine Medical Research Foundation, The University of Western Australia, Ann Helene Toakley Charitable Endowment.
Abstract (Originalsprache)
Recently, an antibody which inhibits the glycoprotein A repetitions predominant (GARP)‐mediated release of active transforming growth factor beta (TGFβ) from the TGFβ propeptide latency‐associated peptide (LAP) showed preclinical activity in a murine model of the chronic myeloproliferative neoplasms (MPN). Consequently, we investigated the expression of the immunosuppressive molecules LAP and GARP on peripheral blood lymphocytes from 56 MPN patients and 11 healthy donors (HD). We found that lymphocytes from patients with MPN express higher levels of LAP and GARP with no strong differences found between the different MPN diagnoses. The impact of clinical parameters on the expression of LAP and GARP by lymphocytes showed that patients with calreticulin ( CALR )mut MPN have increased expression compared with HD and patients with the Januskinase2 ( JAK2 ) mutation. The fraction of lymphocytes bound to activated platelets (aPLT) strongly correlate to LAP and GARP expression suggesting that it is not the lymphocytes themselves but aPLT, which confer the increased expression of GARP and LAP on MPN patient lymphocytes. Notably, no differences in neither platelet counts nor anti‐thrombotic therapy was identified between patients with JAK2 ‐ and CALR mut patients. Analysis of platelet gene expression failed to identify differences in expression of relevant genes between JAK2 ‐ and CALR mut patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, National Center for Cancer Immune Therapy, Herlev University Hospital, Herlev, Denmark.
- Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
- Department of Haematology, Zealand University Hospital, Roskilde, Denmark.
- Department of Clinical Biochemistry, Zealand University Hospital, Koege, Denmark.
- Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Morten Orebo Holmström, Morten Kranker Larsen, Lasse Kjær, Vibe Skov, Belinda B Guo, Hans Carl Hasselbalch
Förderung
- Raine Medical Research Foundation
- The University of Western Australia
- Ann Helene Toakley Charitable Endowment
- Cancer Council Western Australia
- The Ruby Red Foundation
- Novo Nordisk Fonden
Zitieren
APA
Holmström, M. O., Ruders, J. H., Riley, C. H., Larsen, M. K., Grauslund, J. H., Kjær, L., Skov, V., Ellervik, C., Guo, B. B., Linden, M., Hasselbalch, H. C., & Andersen, M. H. (2024). The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets. British Journal of Haematology. https://doi.org/10.1111/bjh.19711
Vancouver
Holmström MO, Ruders JH, Riley CH, Larsen MK, Grauslund JH, Kjær L, et al. The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets. British Journal of Haematology. 2024. doi:10.1111/bjh.19711
BibTeX
@article{Holmstrm2024,
author = {Holmström, Morten Orebo and Ruders, Josephine Hallundbæk and Riley, Caroline Hasselbalch and Larsen, Morten Kranker and Grauslund, Jacob Handlos and Kjær, Lasse and Skov, Vibe and Ellervik, Christina and Guo, Belinda B and Linden, Matthew and Hasselbalch, Hans Carl and Andersen, Mads Hald},
title = {The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19711}
}
EUVIMED